Exact Mass: 295.0419128

Exact Mass Matches: 295.0419128

Found 38 metabolites which its exact mass value is equals to given mass value 295.0419128, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-(4-Chlorophenyl)-1H-pyrazolo[4,3-c]quinolin-3-one

2-(4-Chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3H)-one

C16H10ClN3O (295.051236)

ZINC4390596

C14H14ClNO2S (295.0433734)

5-hydroxy-2-methyl-pyrano[2,3:5,6]chromeno[3,4-c]pyridine-4,8-dione|Schumanniophytin|Schumanniophytine

C16H9NO5 (295.0480704)

7-[(2S)-2-amino-2-carboxylatoethyl]-5-hydroxy-2H-1,4-benzothiazine-3-carboxylate

C12H11N2O5S- (295.0388656)

8-[(2S)-2-amino-2-carboxylatoethyl]-5-hydroxy-2H-1,4-benzothiazine-3-carboxylate

C12H11N2O5S- (295.0388656)

5-Cyclopropyl-4-[(3,4-dichlorophenyl)hydrazinylidene]-3-pyrazolamine

C12H11Cl2N5 (295.03914660000004)

4-Tert-butyl-2-[(5-nitro-2-pyridinyl)thio]thiazole

C12H13N3O2S2 (295.0449158)

2-(2-methoxyethylthio)-N-(1,3,4-thiadiazol-2-yl)benzamide

C12H13N3O2S2 (295.0449158)

4-(3,4-dimethoxybenzylidene)-2-(methylthio)-1,3-thiazol-5(4H)-one

C13H13NO3S2 (295.0336828)

5-HT2B antagonist-1

C11H14BrN5 (295.04325040000003)

5-HT2B antagonist-1 is an orally active 5-HT2B receptor antagonist with an IC50 value of 33.4 nM. 5-HT2B antagonist-1 can be used in studies of diseases characterized by 5-HT2B receptor signaling, such as hepatocellular carcinoma, cardiovascular disease or gastrointestinal disease[1][2].

8-hydroxy-4-methyl-3,11-dioxa-15-azatetracyclo[8.8.0.0²,⁷.0¹³,¹⁸]octadeca-1(10),2(7),4,8,13(18),14,16-heptaene-6,12-dione

C16H9NO5 (295.0480704)

({5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene}methyl)(ethyl)amine

C12H14BrN3O (295.03201740000003)

Exact Mass: 295.0419128

Exact Mass Matches: 295.0419128

2-(4-Chlorophenyl)-1H-pyrazolo[4,3-c]quinolin-3-one

ZINC4390596

5-hydroxy-2-methyl-pyrano[2,3:5,6]chromeno[3,4-c]pyridine-4,8-dione|Schumanniophytin|Schumanniophytine

Tambjamine G

tambjamine E acetate

4-Quinolinemethanol, 2,8-bis(trifluoromethyl)-

(BENZENESULFONYL-FURAN-2-YLMETHYL-AMINO)-ACETIC ACID

N-(2-NITROBENZENESULFONYL)-1,3-DIAMINOPROPANE HYDROCHLORIDE

(4-(N-(4-Fluorophenyl)sulfamoyl)phenyl)boronic acid

ETHYL5-CHLORO-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

ETHYL5-CHLORO-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

SBEC

Methyl (S)-2-(Boc-amino)-4-bromobutyrate

1-THIOPHEN-2-YL-ETHANONE OXIME TOSYLATE

(S)-3-AMINO-5-HEXYNOIC ACIDHYDROCHLORIDE

(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-nitrophenyl carbonate

n-succinyl sulfanilamide sodium salt h&

4-(4-CHLORO-L-CYANOBENZYL)-(2H)-PHTHALAZINONE

6-bromospiro[1,3-dihydroquinazoline-2,4-piperidine]-4-one

ethyl 3-(2-chloro-4-nitrophenylaMino)-2-cyanoacrylate

2-AMINO-4-(3-CHLORO-PHENYL)-5-METHYL-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

4-amino-N-(4-methoxyphenyl)-2-(methylthio)-5-thiazolecarboxamide

N-[2-[(4-chlorophenyl)methylsulfanyl]ethyl]furan-2-carboxamide

7-[(2S)-2-amino-2-carboxylatoethyl]-5-hydroxy-2H-1,4-benzothiazine-3-carboxylate

8-[(2S)-2-amino-2-carboxylatoethyl]-5-hydroxy-2H-1,4-benzothiazine-3-carboxylate

5-Cyclopropyl-4-[(3,4-dichlorophenyl)hydrazinylidene]-3-pyrazolamine

4-Tert-butyl-2-[(5-nitro-2-pyridinyl)thio]thiazole

2-(2-methoxyethylthio)-N-(1,3,4-thiadiazol-2-yl)benzamide

4-(3,4-dimethoxybenzylidene)-2-(methylthio)-1,3-thiazol-5(4H)-one

5-HT2B antagonist-1

5-hydroxy-2-methyl-1,11-dioxa-8-azatetraphene-4,10-dione

{[(5z)-5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}(ethyl)amine

({5'-bromo-4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(ethyl)amine

2-methyl-8h-1,11-dioxa-8-azatetraphene-4,5,10-trione

{[(5z)-3'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}(ethyl)amine

({3'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene}methyl)(ethyl)amine

8-hydroxy-4-methyl-3,11-dioxa-15-azatetracyclo[8.8.0.0²,⁷.0¹³,¹⁸]octadeca-1(10),2(7),4,8,13(18),14,16-heptaene-6,12-dione

({5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene}methyl)(ethyl)amine